UNSPSC 51172506: Sodium chloride/sodium sulfite/sodium thiosulfate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AD200. This VA Drug Class (AD200) classifies this compound as belonging to the group CYANIDE ANTIDOTES.

UNSPSC 51172506 Sodium chloride/sodium sulfite/sodium thiosulfate, a Commodity code, shows limited alignment with actual recent state and local procurement activity. The three most recent opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which concern sodium-based chemical compounds. State and local governments using this code appear to be procuring pharmaceutical products, medical countermeasures, and health-system supplies rather than the industrial or water-treatment chemicals the code nominally covers. The issuing bodies include county health departments, state health and human services commissions, and multi-state cooperative purchasing alliances serving government agencies and healthcare facilities.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 (due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to its Community Health Building. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products for distribution across participating state and local government facilities in Minnesota and Oregon. The code shows substantial miscoding or category scope drift — recent opportunities reflect pharmaceutical procurement, not sodium chemistry products, limiting relevance for vendors in chemical manufacturing or distribution.